These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7325179)

  • 21. Antisubstitution law changes and the hospital formulary system.
    Fink JL
    Am J Hosp Pharm; 1977 Jan; 34(1):90-3. PubMed ID: 831478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multidisciplinary process to determine, communicate, and manage an antibiotic formulary.
    Cook AA; Sanchez ML
    Hosp Pharm; 1992 Oct; 27(10):867-9, 872-4, 882. PubMed ID: 10121423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulary management through therapeutic substitution: factors behind the decision.
    Klapp DL; Doering PL; Russell WL; McCormick WC
    Hosp Formul; 1983 Oct; 18(10):956-61. PubMed ID: 10262827
    [No Abstract]   [Full Text] [Related]  

  • 25. And the beat goes on: formulary restriction, generic substitution, prior authorization, drug utilization, and now therapeutic interchange.
    Burkhart CG
    J Drugs Dermatol; 2004; 3(1):11. PubMed ID: 14964740
    [No Abstract]   [Full Text] [Related]  

  • 26. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P & T Committee formulary requests: criteria for admission.
    Weintraub M; Guttmacher L
    Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacists' and physicians' responses to the South Carolina Product Selection Act of 1978.
    Sumner ED; Karig AW; Hunt HH
    Contemp Pharm Pract; 1982; 5(2):124-9. PubMed ID: 10256911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total formulary review--the easy way.
    Chase K; Meyer JD; Kelly WN
    Hosp Pharm; 1984 Mar; 19(3):159-62. PubMed ID: 10265845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing an effective P & T Committee, Part 2.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Legal format and costs of prescriptions at the Central Hospital in Yaounde, Cameroon].
    Blatt A; Chambon R; Lemardeley P
    Med Trop (Mars); 1997; 57(1):37-40. PubMed ID: 9289607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. State Approaches to Therapeutic Interchange in Community Pharmacy Settings: Legislative and Regulatory Authority.
    Vanderholm T; Klepser D; Adams AJ
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1260-1263. PubMed ID: 30479203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Documentation of drug interchange in the medical record.
    Gannon PM
    Hosp Pharm; 1991 Jan; 26(1):14-6, 18, 22. PubMed ID: 10108660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Key inventory to formulary to cut drug costs.
    Schmieding JL; Sita MJ
    Hospitals; 1980 Sep; 54(17):78-81. PubMed ID: 7399457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulary issues at a pediatric hospital: experience at Children's National Medical Center.
    Cohen GJ; Allen SJ
    Hosp Formul; 1991 Jun; 26(6):500-10. PubMed ID: 10111371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulary management to reduce cost: P & T committee strategies.
    Roberts MJ; Summerfield MR
    Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Communicating P & T guidelines: how one committee meets the challenge.
    Dreyfus R; Bender F
    Hosp Formul; 1987 Jul; 22(7):651-4, 657. PubMed ID: 10282681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P & T Committee interview: Establishing and maintaining a dynamic formulary.
    Rostand S; Lazarus H
    Hosp Formul; 1988 Jan; 23(1):48-53. PubMed ID: 10285373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.